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During craniofacial development, the Hedgehog (HH) signaling pathway is essential for
mesodermal tissue patterning and differentiation. The HH family consists of three protein
ligands: Sonic Hedgehog (SHH), Indian Hedgehog (IHH), and Desert Hedgehog (DHH),
of which two are expressed in the craniofacial complex (IHH and SHH). Dysregulations
in HH signaling are well documented to result in a wide range of craniofacial
abnormalities, including holoprosencephaly (HPE), hypotelorism, and cleft lip/palate.
Furthermore, mutations in HH effectors, co-receptors, and ciliary proteins result in skeletal
and craniofacial deformities. Cranial suture morphogenesis is a delicate developmental
process that requires control of cell commitment, proliferation and differentiation. This
review focuses on both what is known and what remains unknown regarding HH signaling
in cranial suture morphogenesis and intramembranous ossification. As demonstrated from
murine studies, expression of both SHH and IHH is critical to the formation and fusion
of the cranial sutures and calvarial ossification. SHH expression has been observed in
the cranial suture mesenchyme and its precise function is not fully defined, although
some postulate SHH to delay cranial suture fusion. IHH expression is mainly found on
the osteogenic fronts of the calvarial bones, and functions to induce cell proliferation
and differentiation. Unfortunately, neonatal lethality of IHH deficient mice precludes a
detailed examination of their postnatal calvarial phenotype. In summary, a number of basic
questions are yet to be answered regarding domains of expression, developmental role,
and functional overlap of HH morphogens in the calvaria. Nevertheless, SHH and IHH
ligands are integral to cranial suture development and regulation of calvarial ossification.
When HH signaling goes awry, the resultant suite of morphologic abnormalities highlights
the important roles of HH signaling in cranial development.
Keywords: craniofacial abnormalities, Sonic Hedgehog (SHH), Indian Hedgehog (IHH), cranial suture
patterning/signaling, calvarial bone differentiation
INTRODUCTION
Craniofacial morphogenesis, an intricate developmental pro-
cess, begins with the synchronized development of head pri-
mordia, which involves several organizing centers located in
the neural ectoderm, axial mesendoderm, and the cranial
neural crest. The differentiation and spatial patterning of
these tissues must occur before they can be successfully inte-
grated (Hu and Helms, 1999). The Sonic Hedgehog mor-
phogen (SHH) is one of the signals involved in the axial
and dorsoventral definition of craniofacial and limb devel-
opment (Chiang et al., 1996; Capdevila and Johnson, 2000;
Anderson et al., 2012). Dysregulation of the Hedgehog (HH)
signaling pathway results in a wide array of craniofacial
defects including holoprosencephaly (HPE), hypotelorism, and
cyclopia, amongst others (Belloni et al., 1996). Both Indian
Hedgehog (IHH) and SHH have been well studied in carti-
lage and bone patterning throughout the axial, appendicular
and facial skeleton (Hammerschmidt et al., 1997; Capdevila
and Johnson, 2000; Chai and Maxson, 2006). In contrast, the
role of HH signaling in calvarial ossification and cranial suture
morphogenesis is a relatively new and less examined area of
scientific investigation.
The embryonic development of the cranium and cranial suture
complex begins as far back as neural crest cell migration, a
process starting on murine embryonic day 8 (E8) and com-
pleted within 2 days (Slavkin, 1979). In humans, this period
lies approximately between E19 and E38 (Dixon et al., 1997).
After migration of the neural crest, the calvarial mesenchyme
originates from both the paraxial mesoderm and the migrated
cranial neural crest (Noden, 1983). The demarcations between
the neural crest and mesoderm-derived bone have undergone
evolutionary changes resulting in species-specific differences. In
avian skulls this boundary has been found on the caudal bor-
der of the frontal bone and that a portion of the calvarium
was derived from neural crest cells (Noden, 1975; Le Lievre,
1978). Later studies have proposed that avian skull may even arise
entirely from neural crest cells (Couly et al., 1993). Murine stud-
ies, using Wnt1-Cre (a reporter for neural crest origin) mice,
suggest that the entire frontal bone is derived from neural crest
origin, while other skull bones principally originate from the
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paraxial mesoderm (Chai et al., 2000; Jiang et al., 2000, 2002;
Brault et al., 2001; Chai and Maxson, 2006; Ishii et al., 2012).
Nevertheless, the process of cranial skeletogenesis occurs in con-
cert with the expansion of the brain. Neural crest cells originate
from the dorsal neural tube and as the cells migrate they are
pulled by the expansion of the epidermis to form the frontonasal
process. The frontal primordium mesenchyme then forms the
frontal bones, which differentiates into the primary bone plates
(Iseki et al., 1995; Ting et al., 2009). Subsequent growth of the
bone plates occurs until they meet, resulting in formation of a
suture.
Characterized as regions of fibrous tissue between cranial
bones, sutures function as intramembranous osteogenic sites,
permit cranium growth, inhibit bone separation, and absorb
shock (Baer, 1954; Cohen, 1993; Wilkie, 1997; Lenton et al.,
2005). Cranial sutures are distinguished with respect to their adja-
cent cranial bones (i.e., the metopic suture lies between frontal
bones, etc.). It is crucial that sutures remain in an undifferenti-
ated and proliferative state as the brain develops while permitting
the growth of new bone at the suture margins until the they fuse
(Opperman, 2000).
Cranial suture fusion is a process whereby the cells in the
middle of the suture complex mature into osteoblasts that even-
tually fuse into midline sutures (i.e., the sagittal and metopic
sutures), which join end-to-end. In humans all sutures close
around the end of adolescence (Madeline and Elster, 1995). In
contrast, in mice, the transversely situated sutures (lamboid and
coronal sutures), do not undergo ossification and remain over-
lapping and patent. During the stages before physiologic suture
fusion, an imbalance between cell proliferation and osteoblast
differentiation can cause inappropriate suture fusion, or cran-
iosynostosis. Suture synostosis prevents further bone formation
and accommodation of neurocranial growth, leading to cranio-
facial dysmorphology and central nervous system (CNS) impair-
ments. Potential CNS effects of craniosynostosis include elevated
intracranial pressure (Bristol et al., 2004; Hayward and Gonsalez,
2005), high incidence of learning disabilities (Kapp-Simon, 1998;
Panchal et al., 2001; Magge et al., 2002), and impaired eyesight
(Macintosh et al., 2012). Therefore, regulation of cranial suture
morphogenesis is crucial for maintenance of suture patency and
proper physical and cognitive development.
Growth factor regulation is one of the main mechanisms
that coordinate calvarial patterning and ossification. The most
commonly studied signaling pathways regulating suture fusion
include Fibroblast Growth Factor (FGF), Transforming Growth
Factor (TGF-β), and Bone Morphogenetic Protein (BMP) sig-
naling (Longaker, 2001; Warren et al., 2003; Nie et al., 2006a,b;
Rawlins and Opperman, 2008). The dura mater (or outer layer
of meninges) secretes a variety of growth factors in order to reg-
ulate cranial suture fusion and suture patency in a paracrine
fashion (Opperman et al., 1993; Bradley et al., 1997; Cooper
et al., 2012). FGF2 demonstrates a significantmitogenic effect and
thus may stimulate proliferation of osteoprogenitors in the dura
mater and overlying suture mesenchyme (Spector et al., 2002;
Li et al., 2007). As a result, a majority of syndromic synostoses
arise from Fibroblast growth factor receptor (FGFR) mutations
(Cohen, 2009). Additionally, TGF-βs also serves to initiate suture
fusion as there are high levels of TGF-β1 and 2 expression in
fusing as compared to patent cranial sutures (Opperman et al.,
1997, 1999; Ko et al., 2009; Slater et al., 2009). Studies dysregu-
lating TGF-β signaling have also been shown to significantly alter
suture ossification and fate (fusion vs. patency) (Derynck et al.,
1994; Rawlins and Opperman, 2008; Chim et al., 2011). While the
periosteum lies in close proximity in the suture, it does not con-
tribute significantly to the regulation of suture fusion (Opperman
et al., 1994, 1995). The significance of BMP signaling in cra-
nial suture fusions was made clear by studies involving the BMP
antagonist Noggin (Warren et al., 2003). While BMP is expressed
in fusing sutures, the Noggin expression that it induces is coun-
teracted by FGF2 signaling. In comparison to FGF, TGF-β, and
BMP signaling, the role of HH signaling in cranial suture mor-
phogenesis is a relatively new focus of investigation, yet one of
clear importance.
This review will first provide an overview of HH signaling,
including normal signal transduction and pertinent regulators of
HH signaling. Next, a comprehensive review of the known func-
tions of HH signaling in the cranial suture complex is presented.
In addition, the role of HH in endochondral ossification and cra-
nial base formation is examined. Finally, a discussion of what
remains unknown or unclear regarding HH signaling in cranial
suture biology is presented.
AN OVERVIEW OF HEDGEHOG SIGNALING
The activity of the HH pathway was first identified in Drosophila,
and its expression was later found in all vertebrates (Fietz et al.,
1994). Three homologues of the Drosophila HH protein exist
in vertebrates: SHH, IHH, and Desert hedgehog (DHH). DHH
expression is primarily limited to the male reproductive tract,
and the majority of DHH−/− mice do not exhibit mutant phe-
notypes in most tissues (Parmantier et al., 1999; Yao et al.,
2002; Cohen, 2003; Kawai et al., 2010). In contrast, SHH and
IHH are essential to embryonic development, as either SHH-
or IHH-deficient mice demonstrate multiple severe congenital
anomalies and neonatal lethality that will be further discussed
below (Chiang et al., 1996; St-Jacques et al., 1999; Hayhurst
and McConnell, 2003). SHH plays a diverse and key role in
the development of the head process, notochord, ventrolateral
midbrain, and ventral forebrain. SHH also plays an indispen-
sible function in limb development, including limb budding,
anterior-posterior patterning of limb skeleton and regulation of
right/left asymmetry (Capdevila and Johnson, 2000). In regards
to the craniomaxillofacial skeleton, SHH in the forebrain medi-
ates the development of mid and upper face, frontonasal and
maxillary processes (Byrnes et al., 2009). Closely related to SHH
by a gene duplication event (Schlosser and Wagner, 2004), IHH
regulates chondrocyte differentiation and stimulates endochon-
dral bone formation (Cohen, 2003). IHH stimulates the pro-
liferation of chondrocytes at the growth plate and further in
development, osteoblast differentiation; in addition, it also regu-
lates chondrocyte hypertrophic differentiation through a negative
feedback loop involving Ihh-parathyroid hormone-related pro-
tein (PTHrP) (Bitgood and McMahon, 1995; St-Jacques et al.,
1999; Long et al., 2004). As well, IHH promotes ossification
and fusion of the cranial and palatine bones, discussed further
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below (Lenton et al., 2011; Levi et al., 2011). Both SHH and IHH
are found to be crucial regulators of osteogenesis and therefore of
importance in cranial suture biology.
All of the HH homologues undergo the same highly con-
served HH signaling pathway that occurs through a three-step
process. First, the insoluble HH morphogen is converted to a
multimeric form, which renders it soluble and available for diffu-
sion across cell membranes. This HH ligand is subsequently made
active as HH ligands precursors undergo autocatalytic cleavage to
form 19 kD proteins with a C-terminal cholesterol moiety (Porter
et al., 1996; Cohen, 2003) (Figure 1). Palmitoyl acid then modi-
fies the N-terminus, forming a palmitate (Pepinsky et al., 1998).
After these two covalent lipid modifications, the HH ligand is
now active and has an increased affinity for the cell membrane
(Simpson et al., 2009). Second, a large transmembrane protein,
Dispatched, releases the now lipid-anchored protein HH from the
signaling cell, which allows HH binding to the receptor Patched
(PTCH), a transcription inhibitor. After the HH ligand binds
to PTCH, Smoothened (SMO), another transmembrane protein
for downstream signaling, is freed from PTCH repression and
transduces the signal intracellularly. In vertebrates, SMO leads to
the transcription of target genes downstream through interaction
with glioblastoma gene products (Gli) family of transcription fac-
tors (Gli1, Gli2, and Gli3). Recently, the so-called “non-canonical
HH signaling pathway” has been discovered, which utilizes Gli
independent pathways (Jenkins, 2009). This novel HH signaling
has been studied during angiogenesis as well as cancer biology.
However, this non-canonical signaling has not been sufficiently
characterized for its operation in sutures, and will not be further
addressed here (Chinchilla et al., 2010; Spek et al., 2010).
The Gli transcription factors are homologues of Cubitus inter-
ruptus (Ci), a transcription factor mediating HH signaling found
in Drosophila (Huangfu and Anderson, 2006). Both Gli and Ci
function similarly and act as key regulators of targeted gene
expression. Gli proteins have been found to function as transcrip-
tional activators, transcriptional repressors or both. Experiments
have demonstrated that Gli2 and Gli3 both contain an amino-
terminal repressor domain and a carboxyl-terminal activator
FIGURE 1 | Hedgehog pathway. The Hedgehog (HH) ligand precursor
undergoes a series of modifications until reaching an active, multimeric
form (shown in yellow). All three HH ligands then signal through the
same pathway: following multimeric HH ligand release from Dispatched
(DISP) and secretion from the signaling cell, the HH ligand binds to
Patched (PTCH) on the receiving cell, releasing Smoothened (SMO) from
constitutive inhibition (Cohen, 2003). Released SMO then shuttles through
the cilia. This signals activation of the Gli2/3 complex (shown as Gli2/3A),
which promotes gene expression via Gli1, while simultaneously inhibiting
the Gli3 repressor form (shown as Gli3R). In the presence of HH activated
SMO, the Kif3a motor complex promotes Gli2/3A expression and inhibits
repression by Gli3R (Rohatgi and Scott, 2008). HHAT is necessary for
post-translational palmitoylation of HH; in the absence of HHAT, HH
secretion is decreased (Dennis et al., 2012). In the presence of HH, BOC,
CDO, and GAS1 bind to PTCH to form complexes which repress SMO,
allowing downstream signaling through Gli to continue (Izzi et al., 2011).
RAB23 (shown in red) functions as a negative regulator of the HH
pathway, most likely through interaction with the Gli2 activator
and Gli3 repressor forms. Please note, the depiction of SMO as a
7-transmembrane protein and both PTCH and DISP as a
12-transmembrane protein correspond to their respective biological
conformations (De Rivoyre et al., 2006; Cohen, 2010).
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domain that flanks the zinc fingers (Ruiz i Altaba, 1999; Sasaki
et al., 1999; Wong and Reiter, 2008); however, Gli1 does not
contain the repressor domain and so cannot be proteolytically
processed (Ruiz i Altaba, 1998; Dai et al., 1999). Gene analysis has
shown that Gli1 functions solely as a strong transcriptional acti-
vator (Hynes et al., 1997; Lee et al., 1997; Karlstrom et al., 2003).
In mouse development, Gli1 does not appear to be essential since
Gli1−/− mutants are viable and survive from birth to adulthood
and exhibit a normal phenotype (Park et al., 2000; Bai et al.,
2002). In contrast, the other members of the Gli family, Gli2, and
Gli3, are required for organ patterning, such as lung development
and spinal cord patterning (Brewster et al., 2000; Bai et al., 2004;
Rutter et al., 2010). Both Gli2 and Gli3 can act as both activators
and repressors. Their bifunctionality is determined by the pres-
ence of HH signaling. When there are high concentrations of HH
ligands, proteolytic processing of Gli2 andGli3 is inhibited, which
allows for their activator function. Without HH presence, these
transcription factors may undergo cleavage to become repressors
(Wang et al., 2000; Bai et al., 2004; Pan et al., 2006). The devia-
tions of the carboxyl-terminal amino acid sequences of Gli2 and
Gli3 have been found to result in differential processing (Pan
and Wang, 2007). Gli2 proteins have inefficient protein process-
ing and therefore remain transcriptionally active in vivo (Fuccillo
et al., 2006). In contrast, the majority of Gli3 proteins are partially
degraded, thus mainly functioning as a transcription repressor
(Theil et al., 1999; Persson et al., 2002; Rallu et al., 2002). In
summary, the Gli protein family controls HH signaling through
transcription, both in the cranial suture region and throughout
the organism.
CRANIOFACIAL DYSMORPHISM CAUSED BY HEDGEHOG
SIGNALING
In the absence of an active HH ligand or interference with HH
signal transduction, a transcriptional repression of HH target
genes results in a slew of craniofacial anomalies (see Table 1).
Aberrations in Gli3 are known to cause craniofacial dysmor-
phisms in both human and mice models. One result of altered
Gli3 sequence is Greig cephalopolysyndactly syndrome, which
causes metopic synostosis and is characterized by polydactyly
and hypertelorism (Hui and Joyner, 1993; Quinn et al., 2012;
Veistinen et al., 2012). Another caused by mutations in the Gli3
effector is Pallister-Hall Syndrome, with common craniofacial
findings including disrupted midline development and abnor-
malities such as a short nose with flat nasal bridge, and cleft palate
(Kuo et al., 1999; Naruse et al., 2010). In fact, the integral role of
Gli3 as a transcriptional repressor is evident in studies with Gli3
null mice in which excessive osteoblastic proliferation and dif-
ferentiation result in craniosynostotic phenotypes (Shimoyama
et al., 2007). Interestingly, local application of recombinant FGF2
rescues loss of Gli3 as it stabilizes the increased osteoblastic pro-
liferation observed in Gli3 deficient mice (Rice et al., 2010).
HH signaling can also be effected by changes in the physical
environment that transduces the signals of proteins in the HH
pathway.
Primary cilia serve an important and increasingly understood
role in suture biology, as HH transduction initiates at the pri-
mary cilia (Tukachinsky et al., 2010). Studies involving cilial
defects have shown that primary cilia are crucial to HH signaling.
Currently, it is suggested that primary cilia provide an environ-
ment that facilitates interactions amongst the different pathway
components in HH transduction (Ruat et al., 2012). During
HH signaling, intraflagellar transport proteins (IFT), which are
required for the production and preservation of cilia, have been
found to affect the signal transduction of the HH pathway
(Huangfu et al., 2003; Keady et al., 2012; Yang and Wang, 2012).
IFT particles are formed by two complexes that use the Kif3motor
complex and the retrograde dynein motors to selectively import
or export proteins between the cilium and cytoplasm (Ruat et al.,
2012). Signal dependent transfer of PTCH, SMO, andGli proteins
requires ciliary transport in order to activate the HH pathway
(Keady et al., 2012). Studies suggest that following PTCH regu-
lation of SMO, SMO is consequently translocated to the cilium
through the use of IFT proteins and interacts with Gli to pro-
mote Gli activation. Gli activators then move down the cilium to
enter the nucleus and promote HH targeted genes (Huangfu and
Anderson, 2006; Singla and Reiter, 2006). Interestingly, mutations
that disrupt IFT proteins show phenotypes characteristic of SHH
signaling defects. This observation extends to the craniofacial
skeleton. For example, mutations in the IFT protein DYNC2H1,
causes short rib polydactyly syndrome, a lethal autosomal reces-
sive condition that features cerebral and skeletal abnormalities,
such as HPE, in addition to other appendicular malformations
(Dagoneau et al., 2009; Merrill et al., 2009; El Hokayem et al.,
2012). Mutations in another IFT protein, IFT144, also result in
craniofacial anomalies such as craniosynostosis and exencephaly,
which results from deficient ciliogenesis and diminished response
to upstream activation of HH signaling (Ashe et al., 2012). Gene
analysis has found that IFTmotor proteins such as Kif3a (Kinesin-
like protein) are required for signaling of Gli transcription factors
(Haycraft et al., 2005; Huangfu and Anderson, 2005; Liu et al.,
2005). Kif3a conditional knockouts (Kif3a Wnt1-Cre) show a
phenotype with severe cranial dysmorphisms including abnor-
mal openings in the skull vault, associated with displacement
of the neuroectodermal domains of SHH signaling (Brugmann
et al., 2010). Interestingly, Kif3a deficient mouse skulls exhibit
abnormalities partially overlapping with the SHH and IHH null
phenotypes (see discussion below) (Koyama et al., 2007). In
summary, cilia are involved in the regulation of HH signal trans-
duction, although the precise mechanisms of this relationship are
only partially elucidated.
Another potential cause of craniofacial abnormalities includes
exposure to teratogens, which interfere with the HH signaling
pathway. One of the main plant alkaloids that produce these
deformities is the jervine family of alkaloids. Cyclopian defor-
mities from alkaloids were first observed in the offspring of
pregnant sheep grazing onVeratrumCalifornicum. Further exper-
imentation found that these chemical compounds also trigger
clefting and HPE in sheep and other animals by inhibiting the
response of target tissues to HH ligands (Binns et al., 1963).
The structural similarity of these alkaloids to cholesterol allows
them to inhibit cholesterol’s stimulatory effect on HH signal-
ing (Cooper et al., 1998; Chen et al., 2002). For example, the
steroidal alkaloid Cyclopamine (11-deoxojervine) causes terato-
genic effects through direct binding of cyclopamine to the SMO
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Table 1 | Genetic disorders in the hedgehog signaling network.
Syndrome name Mutated gene MIM Function of proteins* Skeletal phenotypes*
Greig cephalopolysyndactyly
syndrome
Gli3 175700 Transcriptional repressor of HH
signaling
Pre- and post-axial polydactyly and syndactyly
of hands and feet, slight hypertelorism, high
prominent forehead
Pallister-hall syndrome Gli3 146510 Transcriptional repressor of HH
signaling
Disrupted midline development and
craniofacial abnormalities including a short
nose with flat nasal bridge and cleft palate
NBCCS PTCH 109400 SHH receptor, inhibits SMO
expression
Basal cell carcinomas, macroencephaly, cleft
lip/palate, intracranial ectopic calcifications and
facial dysmorphisms
Carpenter’s syndrome RAB23 201000 Negative regulator of SHH Syndactyly, brachydactyly with shortening or
absence of middle phalanges,
craniosynostosis of midline and coronal
sutures
Acrocapitofemoral dysplasia IHH 607778 HH ligand Clinically short stature with short limbs,
brachydactyly, shortening or loss of middle
phalanges
Holoprosencephaly 1 GAS1 236100 Co-receptor of PTCH Missing phalanges and anterior digit
syndactyly
Holoprosencephaly 11 CDO 614226 Co-receptor of PTCH Lack of maxillary inscisors, primary palate,
hypoplasia of the cartilage of the nasal septum
– BOC – Co-receptor of PTCH No abnormalities are observed in BOC−/−
mutants alone. However, BOC and CDO
mutants exhibit severe craniofacial midline
abnormalities such as elongated nose, cleft lip,
and hypotelorism.
Asphyxiating thoracic dystrophy 3,
Short ribpolydactyly syndrome,
type II and type III
DYNC2H1 613091,
263520,
263510
IFT Protein, Ciliogenesis, signal
transduction of HH pathway
Short rib polydactyly phenotype, shortened
long bones, a narrow rib cage and polydactyly,
variable malformations including cleft lip/palate
Asphyxiating thoracic dystrophy 5,
Cranioectodermal dysplasia 4
IFT144 614376,
614378
IFT Protein, Ciliogenesis, signal
transduction of HH pathway
Polydactyly, truncated ribs, craniosynostosis,
exencephaly, reduced palatine bones and
misshapen maxillary bones
– HHAT 206500,
202650
Post-translational palmitoylation
of HH proteins
Midface hypoplasia, agenesis of the jaw, loss
of skeletal central bones, apoptosis in
craniofacial mesenchyme
*Data from (Temtamy, 1966; Robinson et al., 1985; Shanley et al., 1994; Wild et al., 1997; Kuo et al., 1999; Lee et al., 2001; Liu et al., 2001, 2002; Cole and Krauss,
2003; Hellemans et al., 2003; Johnston et al., 2005; Zhang et al., 2006, 2011; Lo Muzio, 2008; Keaton et al., 2010; Naruse et al., 2010; Ashe et al., 2012; Dennis
et al., 2012).
Abbreviations: GAS, growth arrest specific; HH, hedgehog; HHAT, hedgehog acyltransferase; IFT, intraflagellar transport; IHH, indian hedgehog; NBCCS, nevoid basal
cell carcinoma syndrome; PTCH, patched; SHH, sonic hedgehog; SMO, smoothened.
heptahelical bundle thereby creating a PTCH independent path-
way, thus resulting in HH pathway inhibition (Incardona et al.,
2000; Chen et al., 2002). Cyclopamine is one of the causes of
embryonic deficiency of midline and lower medial nasal promi-
nence tissue, resulting in severe cranial defects including lateral
cleft lip, cleft palate, and the cyclopia phenotype in many ani-
mal models including zebrafish and mice (Lipinski et al., 2010;
Buttner et al., 2012).
Genetic mutations, rather than exposure to jervines, repre-
sent the major source of HH signaling abnormalities causing
congenital dysmorphisms in humans. Currently, one third of all
birth defects are craniofacial abnormalities, with HPE being the
most common developmental disorder of the forebrain (Gorlin
et al., 1990; Ming and Muenke, 1998; Ming et al., 1998). Despite
the rare live-birth prevalence of 1 in 10,000 HPE infants, it
may be as common as 1 in 250 conceptuses by some estimates
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(Vaz et al., 2012). In fact, SHH was the first gene identified to
cause HPE inmice and humans from nonsensemutations or dele-
tions that result in loss of function (Odent et al., 1999). In clinical
studies, familial forms of HPE involve SHH gene mutations in
up to 23% of affected families; much greater than the percent-
age of non-syndromic mutations, 1% (Roessler et al., 1997; Ming
et al., 1998). SHH gene mutations are also responsible for lip and
palatal defects as SHH signaling pathways regulate the epithelium
and mesenchyme interactions that promote cell proliferation and
palatal growth (Murray and Schutte, 2004). Additionally, IHH
gene mutations, such as additional copies of the IHH locus, are
associated malformations that result in syndactyly and craniosyn-
ostosis (Klopocki et al., 2011). Mutations in IHH can also cause
acrocapitofermoral dysplasia, an autosomal recessive skeletal dys-
plasia resulting in shortening or loss of themiddle phalanges (Gao
et al., 2001; Hellemans et al., 2003; Byrnes et al., 2009).
Other gene mutations that induce HPE and result in HH
pathway dysregulation involve PTCH, Growth arrest-specific 1
(GAS1), CDO, and BOC (Roessler and Muenke, 1998; Seppala
et al., 2007; Allen et al., 2011; Bae et al., 2011; Zhang et al., 2012).
CDO and BOC, the external binding domains of SHH, GAS1, the
co-receptor of PTCH, and PTCH directly interact to activate the
Gli transcription pathway (Izzi et al., 2011). GAS 1 has been found
to promote SHH signaling in embryological development while
being negatively regulated in response to SHH signaling (Allen
et al., 2011). GAS 1 mutant mice have demonstrated various
phenotypes similar to reduced SHH signaling (Liu et al., 2002).
Co-existing CDO and GAS1 mutations in mice have resulted in
HPE, therefore demonstrating these two co-receptors are essen-
tial to proper cranial patterning (Bae et al., 2011). Likewise, CDO
and BOC double mutants also exhibit the HPE phenotype as
well as extreme neural patterning defects. Mutations in BOC
alone result in viable offspring with no HPE. Studies suggest
that this absence may be compensated for by CDO, indicat-
ing that the two have similar functions (Zhang et al., 2012).
Also, hedgehog acyltransferase (HHAT) loss of function decreases
HH secretion and leads to the HPE phenotype; HHAT is neces-
sary for modification of HH proteins (Chen et al., 2004; Dennis
et al., 2012; Hardy and Resh, 2012). Yet another genetic muta-
tion in the HH pathway is found in the mutation of the PTCH
chromosome located on 9q22.3–q31 (Farndon et al., 1992). The
loss of normal PTCH function leads to increased HH signal-
ing and is thought to result in Nevoid Basal Cell Carcinoma
Syndrome (NBCCS). This phenotype is characterized by basal
cell carcinomas, macroencephaly, cleft lip and palate, intracra-
nial ectopic calcifications, and facial dysmorphisms (Evans et al.,
1993; Shanley et al., 1994; Lo Muzio, 2008; Zhang et al., 2011).
Genetic mutations in regulator genes of HH signaling may also
cause calvarial dysmorphisms. A mutation in the RAB23 gene
leads to a dysfunctional repressor of HH signaling. This results
in Carpenter’s Syndrome, characterized by fusion of the mid-
line sutures, obesity and syndactyly (Eggenschwiler et al., 2001;
Jenkins et al., 2007). In summary, a substantial number of known
human craniofacial anomalies in the HPE spectrum arise from
HH and related genes mutations. See Table 1 for a summary of
syndromes, gene mutations, and resultant craniofacial dysmor-
phisms.
ROLE OF HEDGEHOG SIGNALING IN CRANIAL SUTURE
MORPHOGENESIS
Both SHH and IHH ligands have demonstrated importance in
cranial suture morphogenesis. Studies have identified discrete
expression patterns of SHH vs. IHH ligands in the developing
skull, which are distinct and indicate probable differences in
function (Figure 2). Murine studies have shown that SHH gene
expression in the skull occurs at the end of embryonic devel-
opment (from E18 and onwards) in a discontinuous pattern in
the osteogenic fronts of the midline suture mesenchyme, but is
absent in the coronal sutures (Kim et al., 1998). However, other
investigators found contradicting evidence of weak SHH expres-
sion in the parietal bones of E16.5 mice, as well as absent SHH
expression in the midline suture mesenchyme (Lenton et al.,
2011). Thus, the true domains of SHH expression are relatively
ill defined. IHH is present during calvarial osteoblastic devel-
opment and is expressed during osteoblast proliferation at the
osteogenic fronts in mice, (the leading edge of the ossifying cal-
varial bone; Jacob et al., 2007). In another study, IHH expression
was also found in the sagittal suture mesenchyme albeit to a lesser
degree than in ossifying bones and osteogenic fronts in E17.5 mice
FIGURE 2 | HH Ligand expression and function in cranial suture
morphogenesis. Indian Hedgehog (IHH) is observed in the cranial bones
(light blue), primarily at the osteogenic front (dark blue) (1, Jacob et al.,
2007; 2, Lenton et al., 2011). In this figure, solid arrows represent
consistent observations while dashed arrows represent postulated
pathways. Studies have shown that IHH functions to increase new bone
formation at the osteogenic fronts, likely through its upregulation of BMP2
and BMP4 (2, Lenton et al., 2011). Fibroblast growth factor (FGF) has been
shown to promote BMP2/4 (3, Sahar et al., 2005) and is highly expressed in
dura matter and is one of the main diffusible growth factors inducing sutural
fusion (4, Li et al., 2007). In contrast, SHH has been observed to be
expressed in a patched pattern in the midline suture mesenchyme (shown
in red), although some disagreement regarding its expression pattern exists
(2, Lenton et al., 2011). The function of SHH is less clear, although it has
been postulated to function in maintaining suture patency (5, Kim et al.,
1998). SHH may increase mesenchymal proliferation and suture
mesenchyme thickness via promotion of MSX2 (6, Alappat et al., 2003),
and similarities are present between the expression of SHH, MSX2, and
BMP expression during neonatal craniofacial suture development
(7, Liem et al., 2000; 8, Santagati and Rijli, 2003).
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(Lenton et al., 2011). Thus, the expression patterns of SHH and
IHH differ in the cranial suture complex, although some discrep-
ancies regarding the precise domains of SHH expression exist in
the literature.
The domain-specific HH ligand expression has led investi-
gators to examine different plausible functions for SHH and
IHH ligands. The predominant presence of SHH in the suture
mesenchyme and its overlapping expressing pattern with mes-
enchymal cell proliferation has led some to postulate that SHH
has a role in maintaining suture patency (Kim et al., 1998). In
fact, SHH may increase mesenchymal proliferation and suture
mesenchyme thickness via promotion of MSX2, Muscle Segment
Homeobox, a homeobox gene present in osteoblastic cells, in con-
cert with BMP4 signaling (Alappat et al., 2003). Unlike other
cytokines, which are concentrated in the dura mater of cranial
sutures, SHH/IHH expression does not appear to be signifi-
cantly derived from the underlying dura mater. In this way,
HH signaling likely functions in a much different way than,
for example, FGF2 or TGF-β (Mehrara et al., 1999; Moursi
et al., 2002; Li et al., 2007; Gosain et al., 2009). In contrast,
IHH is expressed by calvarial osteoblasts and disruption of IHH
signaling impairs osteoblastogenesis (Murakami et al., 1997).
IHH expression indicates that IHH induces PTCH and BMP2/4
expression, which results in intramembranous bone formation
at the osteogenic fronts during intramembranous ossification
and later suture fusion (Jacob et al., 2007; Lenton et al., 2011).
Toward the completion of physiologic suture fusion, a decrease
in osteoblast proliferation is observed, which coincides with a
decrease in IHH expression. Another theory, although less fre-
quently suggested, is that IHH functionally represses osteogenic
lineage differentiation and that loss of IHH results in prema-
ture osteoprogenitor cell differentiation (Abzhanov et al., 2007).
However, later studies by other research groups have not con-
curred with this observation (Lenton et al., 2011). Finally, IHH
expression on the bony interfaces of synostotic rabbits may
support the role of IHH in premature suture fusion (Nott
et al., 2002a). Overall, the current available data suggests that
SHH may prevent suture fusion and that IHH promotes cal-
varial ossification and sutural fusion. The idea that different,
even opposing effects can result from two morphogens which
use the same conserved pathway is a complex concept. Future
research directly addressing this question may yield further
insight.
Loss-of-function experiments involving either SHH or IHH
results in profound craniofacial dysmorphisms. SHH−/− animals
die before or shortly after birth with a variety of developmen-
tal defects, including absence of distinct forelimb and hindlimb
structures, and a dysostoic calvarial phenotype (McMahon et al.,
2003). Unfortunately, dorsal midline structures fail to form and
therefore null animals demonstrate secondarily impeded cal-
varial ossification (Chiang et al., 1996). In addition, it has
been found that when SHH signaling is blocked in the brain
but SHH is also applied early to the frontonasal ectodermal
zone, the formation of the face and upper jaw is signifi-
cantly improved. This suggests that the SHH signaling, which
mediates brain to face interaction, is time-dependent (Chong
et al., 2012). Approximately half of IHH−/− mice die during
mid-gestation due to yolk sac defects, while the remainder dies
at birth, and is attributed to rib cage deformities and respira-
tory failure (Byrd et al., 2002). The IHH−/− mouse demon-
strates a dysostotic phenotype with reduced calvarial bone size
and ossification, and grossly widened cranial sutures (St-Jacques
et al., 1999; Razzaque et al., 2005; Kolpakova-Hart et al., 2008).
However, unlike the SHH null mouse, the IHH null mouse
cranial phenotype is not secondary to underlying CNS dysge-
nesis. Further studies demonstrated that reduced ossification
in the IHH−/− mouse is accompanied by global reduction of
osteogenic markers and reduced BMP2/4 expression (Lenton
et al., 2011). Overall, loss of function studies have suggested that
IHH has a pro-osteogenic effect in calvarial ossification, while
SHH studies are difficult to interpret due to widespread CNS
malformations.
Both SHH and IHH ligands also interact with other signaling
pathways in the developing skull, the most well studied of which
are BMPs. BMPs, part of the TGF-β superfamily of growth factors,
were first identified by their ability to induce ectopic ossification
(Wozney et al., 1988). Currently, BMPs, such as BMP2, are in
wide clinical use as a bone graft substitute for spinal fusion (Deyo
et al., 2012; Hagen et al., 2012). The expression of the BMP signal-
ing antagonist Noggin has been shown to be a critical regulator
of cranial suture fusion (Warren et al., 2003; Jacob et al., 2007).
In many studies, similarities were found between the patterning
of SHH and BMP expression during neonatal craniofacial suture
development (Liem et al., 2000; Santagati and Rijli, 2003) as well
as with the transcription factor MSX2, a transcriptional repres-
sor of neural crest-derived cells (Hodgkinson et al., 1993; Towler
et al., 1994; Kim et al., 1998; Takahashi et al., 2001). However, the
exact functional importance of SHH/BMP/MSX2 co-expression
in the developing calvaria is not fully elucidated (Lallemand et al.,
2009). Investigators have postulated that IHH also interacts with
BMP signaling, and as previously mentioned, the IHH−/− mouse
demonstrates reduced calvarial BMP2/4 expression (Lenton et al.,
2011). In addition, in vitro studies in suture mesenchymal cells
found that IHH positively regulated BMP2 and BMP4 transcript
abundance, associated with upregulation of osteogenic markers
(Lenton et al., 2011). In sum, this data suggests that IHH lies
upstream of BMP2/4 signaling and may be a part of the regula-
tory network that controls BMP expression, thereby influencing
cranial ossification. In addition, and although not thoroughly
investigated, HH signaling likely interacts with FGF signaling
(including FGF-2 and FGF-9). FGF2/9 expression peaks during
physiologic suture fusion (Fakhry et al., 2005), and activating
mutations in FGFR-2 are the main cause of syndromic synosto-
sis (McGillivray et al., 2005; Marie et al., 2008). The interactions
between FGF and HH signaling have been more thoroughly stud-
ied in facial development, including the coordinated development
of the medial nasal prominence (Hu et al., 2003). Studies sug-
gest that retinoid signaling mediates FGF-8 and SHH expression
and synchronizes the development of the face (Schneider et al.,
2001). While coordinate effects of HH/FGF signaling certainly
exist in cranial suture, a precise characterization of this link has
yet to be determined. In summary, strong data exist to sup-
port regulation of BMP signaling by both SHH and IHH in the
calvaria.
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ROLE OF HEDGEHOG SIGNALING IN ENDOCHONDRAL
PROCESSES
Another important aspect of HH signaling involves endochon-
dral ossification, which is the process of bone development in
the majority of bones in the axial and appendicular skeleton, as
well as the cranial base (Nagayama et al., 2008). In contrast to
intramembranous ossification (discussed previously), endochon-
dral skeletogenesis occurs as mesenchymal cells differentiate into
chondrocytes. As the cartilage enlarges, hypertrophic chondro-
cytes regulate matrix mineralization, vascularization and chon-
droclast attraction. As chondrocytes proliferate they are replaced
by osteoblasts, which provide the scaffold for bone growth
(Kronenberg, 2003). The cranial base is formed through endo-
chondral ossification, in which the chondrocranium is formed
and replaced by bones. These individual bones are connected by
synchondroses, cartilaginous structures, which are similar to long
bone growth plates (Nie, 2005). As with intramembranous bones,
HH signaling is known to play an integral role in cranial base
development (Figure 3).
SHH regulates craniofacial morphogenesis by altering the
IHH/PTHrP negative feedback loop. Overexpression of SHH
increases the amount of IHH inhibitor, PTHrP, thereby resulting
in the failure of the cranial base to fully develop (Tavella et al.,
2004). IHH works to delay the differentiation of chondrocytes
through synthesis of PTHrP, which works on the PTH/PTHrP
FIGURE 3 | Hedgehog pathway in the cranial base. IHH, expressed in
the pre-hypertrophic zones of growth plates, increases chondrocyte
proliferation through increased expression of PTCH, a process mediated by
intracellular component EVC (Long et al., 2001; Ruiz-Perez et al., 2007;
Pacheco et al., 2012). Through a negative feedback loop, IHH also delays
chondrocyte differentiation in order to sustain early chondrocyte production
through synthesis of PTHrP, an IHH inhibitor (Lanske et al., 1996; Vortkamp
et al., 1996; Kronenberg, 2003). ∗ IHH also regulates craniofacial
morphogenesis through altering the IHH/PTHrP negative feedback loop,
though it is primarily expressed in the spheno-occipital synchondroses
(Tavella et al., 2004).
receptors in chondrocytes (Lanske et al., 1996). However, IHH
is not present in the earliest stages of cranial base formation
and patterning, as opposed to SHH, which indicates that their
functions are not redundant (Nie et al., 2005). Increased SHH
expression during later developmental period strongly correlates
with IHH, and suggests that both IHH and SHH control subse-
quent bone formation in the cranial base. IHH, nonetheless, is
the key regulator for endochondral ossification and is secreted by
prehypertrophic chondrocytes and early hypertrophic chondro-
cytes (St-Jacques et al., 1999). IHH mainly functions to inhibit
the progress of immature chondrocyte development in order to
sustain early chondrocyte production (Vortkamp et al., 1996;
Kronenberg, 2003). IHH in chondrocytes increases expression
of PTCH, which then can activate SMO, allowing for increased
chondrocyte proliferation (Long et al., 2001). Experiments with
mice have shown that IHH regulates endochondral ossification
in concert with a number of other proteins, including Ellis-van
Creveld protein (EVC) and Kif3a (discussed below). IHH insti-
gates the proliferation of chondrocytes and regulates maturation
to promote cranial base elongation.
IHH is expressed in the pre-hypertrophic zones of growth
plates while SHH expression is found in proximity to the spheno-
occipital synchondroses. As the posterior portion of the cranial
base is highly receptive to SHH, proper ossification occurs in both
wild type and IHH−/− mice. However, the anterior intrasphe-
noidal synchondrosis appears to be less susceptive to SHH, result-
ing in IHH−/− mice with defective ossification in this area (Young
et al., 2006). In addition IHH−/− mice show ectopic calcifica-
tion in the cartilaginous synchondroses between the basioccipital
and exoccipital bones in the cranial base and delayed hyper-
trophic chondrocyte differentiation (St-Jacques et al., 1999). This
delayed differentiation also results in IHH−/− possessing disor-
ganized synchrondosis growth plates and defects arise between
IHH-producing pre-hypertrophic chondrocytes and PTHrP pro-
liferating chondrocytes (Young et al., 2006). The many abnor-
malities produced from the IHH−/− phenotype demonstrate the
integral part that IHH plays within cranial base synchondrosis
and chondrogenesis.
Additionally, mutations in proteins involved in IHH signaling
also contribute to anomalies in the cranial base. EVC medi-
ates signaling in the IHH pathway and is required for control
over the rate of chondrocyte hypertrophy (Ruiz-Perez et al.,
2007; Pacheco et al., 2012). EVC −/− mice exhibit morpho-
logical defects of the cranial base including midline gaps and
partially fused basisphenoid suture in the neonatal stage (Pacheco
et al., 2012). EVC −/− mice demonstrate a decreased expression
in IHH downstream genes, such as PTCH and Gli1, suggesting
that EVC is an intracellular component of the IHH signaling
pathway. The motor protein Kif3a, as discussed earlier with its
function intramembranous bone defects, also regulates the devel-
opment of the cranial base. In Kif3a-deficient mice, there is a
delay in chondrocyte maturation and hypertrophy, as IHH has
an increased gradient of expression throughout the upper growth
plate and IHH receptors, such as PTCH, are reduced (Koyama
et al., 2007). Thus, IHH is required for synchondrosis organi-
zation and function, and disrupted regulation of IHH signaling
by EVC or Kif3a results in significantly abnormal cranial base
phenotypes.
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UNRESOLVED CONCEPTS
While a number of studies have addressed the importance of HH
signaling in cranial vault ossification and cranial suture biology,
there are many questions that remain unanswered. Firstly, the
precise expression pattern of SHH in the cranial suture is not
yet agreed upon. Previous studies have found that SHH expres-
sion is principally observed in the ectodermal elements of the
skull rather than in the bone or suture mesenchyme. In fact,
using a reporter for HH activity, nearly complete loss of HH
activity was observed in the skull and mesenchyme of IHH−/−
null animals (Lenton et al., 2011). This suggests that SHH may
not be as relevant to calvarial ossification as other researchers
suggest. However, through the use of in situ hybridization for
SHH, expression was found on the sagittal and metopic sutures
(Kim et al., 1998). This ambiguity could be the result of dif-
ferent timepoints of analysis (E16 vs. E18) or differences in
experimental methodology. Secondly, there exist a large num-
ber of in vitro studies that demonstrate the basic pro-osteogenic
effects of SHH (Yuasa et al., 2002; van der Horst et al., 2003;
James et al., 2010, 2012; Tian et al., 2012). These studies, which
have used diverse cell types including pre-osteoblastic cell lines
and primary mesenchymal stem cell sources, would contradict
the hypothesis that SHH functions to prevent suture ossifica-
tion. In addition, a study on craniosynostotic rabbits documented
increased expression of SHH in craniosynostotic sutures, (Nott
et al., 2002b) and SHH overexpression, which simulates loss of
PTCH function, has resulted in the absence of calvarial bones in
the NBCCS mouse phenotype (Hu and Helms, 1999; Cobourne
et al., 2009), further complicating the role of SHH in suture
morphogenesis. In summary, the exact endogenous function of
SHH on calvarial ossification has yet to be fully elucidated, either
as an inhibitor or inducer of calvarial ossification/suture fusion.
Thirdly, it remains uncertain if IHH and SHH in fact have
redundant or even opposing functions in regulating calvarial ossi-
fication. Indeed as IHH and SHH function through the same cell
surface receptor, it is difficult to determine a manner in which
there would have antagonistic effects. A potential method to clar-
ify the specific functions of Indian vs. Sonic may be through
the use of bone specific knockout mice, allowing for examina-
tion of postnatal bone phenotypes in the absence of specific HH
ligands.
CONCLUSIONS
SHH and IHH have critical, sometimes synergistic, and cur-
rently debated biological roles in cranial suture development.
Disruptions in either signaling ligand result in various defects in
the development of cranial sutures. Examination of craniofacial
defects arising from HH signaling abnormalities will provide new
insights into the basic functions of the HH pathway in embryoge-
nesis and patterning, and later bone and cartilage differentiation.
Although much is known, there remain numerous questions for
future study. Such questions include: (1) the precise function of
SHH in cranial suture development, (2) whether IHH and SHH
have different functions in the calvaria, and (3) improved under-
standing of the intersection of HH with other signaling pathways
in craniofacial patterning, such as BMP signaling.
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